Clinical trial
Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals
NCT01293123
Study timeline
Study start (unknown)2011-12-01Date precision: month
Registry last updated2019-10-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIVunresolved
Interventions
RaltegravirDRUG · verified · RxNorm: raltegravir
EfavirenzDRUG · verified · RxNorm: efavirenz
Sponsors & collaborators
University of California, San Diegolead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01293123 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.